For IBD-specific agents, pH-dependent formulations such as delayed-release mesalamine and enteric-coated budesonide may be of particular concern, as prolonged gastric retention could alter their site-specific release profiles
What to Know About Weight Loss Drugs By Lizzie Streit, MS, RDN, LD Anti-obesity medications are getting more attention these days, especially with the Food and Drug Administrations (FDA) approval of semaglutide (Wegovy) for long-term use
Can GLP-1 medications reduce milk supply
Because the evidence is incomplete
Obesity (Silver Spring) 29 , 985994 (2021)
Millions of people take antidepressants daily, and an increasing number also pursue weight loss treatment with GLP-1 medications like semaglutide